104 related articles for article (PubMed ID: 18802996)
1. The usefulness of a perfect parasite.
Vassilopoulos G; Rethwilm A
Gene Ther; 2008 Oct; 15(19):1299-1301. PubMed ID: 18802996
[No Abstract] [Full Text] [Related]
2. Foamy virus vectors come of age.
Williams DA
Mol Ther; 2008 Apr; 16(4):635-6. PubMed ID: 18362918
[No Abstract] [Full Text] [Related]
3. Long-term follow-up of foamy viral vector-mediated gene therapy for canine leukocyte adhesion deficiency.
Bauer TR; Tuschong LM; Calvo KR; Shive HR; Burkholder TH; Karlsson EK; West RR; Russell DW; Hickstein DD
Mol Ther; 2013 May; 21(5):964-72. PubMed ID: 23531552
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of canine leukocyte adhesion deficiency by foamy virus vectors.
Bauer TR; Allen JM; Hai M; Tuschong LM; Khan IF; Olson EM; Adler RL; Burkholder TH; Gu YC; Russell DW; Hickstein DD
Nat Med; 2008 Jan; 14(1):93-7. PubMed ID: 18157138
[TBL] [Abstract][Full Text] [Related]
5. Gene therapy of canine leukocyte adhesion deficiency using lentiviral vectors with human CD11b and CD18 promoters driving canine CD18 expression.
Hunter MJ; Tuschong LM; Fowler CJ; Bauer TR; Burkholder TH; Hickstein DD
Mol Ther; 2011 Jan; 19(1):113-21. PubMed ID: 20859258
[TBL] [Abstract][Full Text] [Related]
6. Treatment of canine leukocyte adhesion deficiency by foamy virus vectors expressing CD18 from a PGK promoter.
Bauer TR; Olson EM; Huo Y; Tuschong LM; Allen JM; Li Y; Burkholder TH; Russell DW
Gene Ther; 2011 Jun; 18(6):553-9. PubMed ID: 21228879
[TBL] [Abstract][Full Text] [Related]
7. Large animal models for foamy virus vector gene therapy.
Trobridge GD; Horn PA; Beard BC; Kiem HP
Viruses; 2012 Dec; 4(12):3572-88. PubMed ID: 23223198
[TBL] [Abstract][Full Text] [Related]
8. Gene therapy for canine leukocyte adhesion deficiency with lentiviral vectors using the murine stem cell virus and human phosphoglycerate kinase promoters.
Hunter MJ; Zhao H; Tuschong LM; Bauer TR; Burkholder TH; Persons DA; Hickstein DD
Hum Gene Ther; 2011 Jun; 22(6):689-96. PubMed ID: 21275758
[TBL] [Abstract][Full Text] [Related]
9. Lentiviral vectors incorporating a human elongation factor 1alpha promoter for the treatment of canine leukocyte adhesion deficiency.
Nelson EJ; Tuschong LM; Hunter MJ; Bauer TR; Burkholder TH; Hickstein DD
Gene Ther; 2010 May; 17(5):672-7. PubMed ID: 20164857
[TBL] [Abstract][Full Text] [Related]
10. Genetics, biology and clinical management of myeloid cell primary immune deficiencies: chronic granulomatous disease and leukocyte adhesion deficiency.
Malech HL; Hickstein DD
Curr Opin Hematol; 2007 Jan; 14(1):29-36. PubMed ID: 17133097
[TBL] [Abstract][Full Text] [Related]
11. Simian foamy virus vectors. Preparation and use.
Park J; Mergia A
Methods Mol Med; 2002; 69():319-33. PubMed ID: 11987786
[No Abstract] [Full Text] [Related]
12. Lentiviral Vector-Mediated Correction of a Mouse Model of Leukocyte Adhesion Deficiency Type I.
Leon-Rico D; Aldea M; Sanchez-Baltasar R; Mesa-Nuñez C; Record J; Burns SO; Santilli G; Thrasher AJ; Bueren JA; Almarza E
Hum Gene Ther; 2016 Sep; 27(9):668-78. PubMed ID: 27056660
[TBL] [Abstract][Full Text] [Related]
13. Development of foamy virus vectors.
Vassilopoulos G; Josephson NC; Trobridge G
Methods Mol Med; 2003; 76():545-64. PubMed ID: 12526184
[No Abstract] [Full Text] [Related]
14. Foamy virus vectors: an awaited alternative to gammaretro- and lentiviral vectors.
Rethwilm A
Curr Gene Ther; 2007 Aug; 7(4):261-71. PubMed ID: 17969559
[TBL] [Abstract][Full Text] [Related]
15. Unique integration profiles in a canine model of long-term repopulating cells transduced with gammaretrovirus, lentivirus, or foamy virus.
Beard BC; Keyser KA; Trobridge GD; Peterson LJ; Miller DG; Jacobs M; Kaul R; Kiem HP
Hum Gene Ther; 2007 May; 18(5):423-34. PubMed ID: 17518616
[TBL] [Abstract][Full Text] [Related]
16. Gene delivery the key to gene therapy: the case for foamy viruses.
Erlwein O; McClure M
Ther Deliv; 2011 Jun; 2(6):681-4. PubMed ID: 22822501
[TBL] [Abstract][Full Text] [Related]
17. Efficiency of different fragment lengths of the ubiquitous chromatin opening element HNRPA2B1-CBX3 in driving human CD18 gene expression within self-inactivating lentiviral vectors for gene therapy applications.
Gopinath C; Chodisetty S; Ghosh A; Nelson EJR
Gene; 2019 Aug; 710():265-272. PubMed ID: 31200085
[TBL] [Abstract][Full Text] [Related]
18. Leukocyte adhesion deficiency in children and Irish setter dogs.
Bauer TR; Gu YC; Creevy KE; Tuschong LM; Embree L; Holland SM; Sokolic RA; Hickstein DD
Pediatr Res; 2004 Mar; 55(3):363-7. PubMed ID: 14711903
[TBL] [Abstract][Full Text] [Related]
19. Progress and prospects: foamy virus vectors enter a new age.
Erlwein O; McClure MO
Gene Ther; 2010 Dec; 17(12):1423-9. PubMed ID: 20631802
[TBL] [Abstract][Full Text] [Related]
20. Construction and characterization of efficient, stable and safe replication-deficient foamy virus vectors.
Bastone P; Romen F; Liu W; Wirtz R; Koch U; Josephson N; Langbein S; Löchelt M
Gene Ther; 2007 Apr; 14(7):613-20. PubMed ID: 17203107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
